Ocular surface changes associated with belantamab mafodotin treatment

Journal article

Peer reviewed

Seyyedehfatemeh Ghalibafan, Kwaku A Osei, James E Hoffman and Alfonso L Sabater

Graefe's archive for clinical and experimental ophthalmology

2023-05-22

PMID: 37212873

Abstract

Dry eye

Belantamab mafodotin

Tear Film

Multiple myeloma

Corneal toxicity

2 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.130 Lymphomas; 1.130.617 Multiple Myeloma
Web Of Science research areas: Ophthalmology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Ocular surface changes associated with belantamab mafodotin treatment
Creators: Seyyedehfatemeh Ghalibafan - University of Miami
Kwaku A Osei - University of Miami
James E Hoffman - Sylvester Comprehensive Cancer Center
Alfonso L Sabater - University of Miami
Publication Details: Graefe's archive for clinical and experimental ophthalmology
Grant note: P30EY014801 / NIH Center Core Grant
Academic Unit: UMMG Department of Ophthalmology; Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 37212873
Record Identifier: 991031802716602976